Skip to main content
ImmuneCited

Pelargonium sidoides لـ Acute Bronchitis

A

Meta-analyses demonstrate Pelargonium sidoides (EPs 7630) may significantly reduce bronchitis symptom severity and working inability. Approved as a medicine for respiratory infections in multiple countries. RCT showed working inability decreased to 16% vs 43% in placebo group after 7 days.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dpelargonium\u002Dsidoides\u0026condition\u003Dacute\u002Dbronchitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

الخلاصة

Meta-analyses demonstrate Pelargonium sidoides (EPs 7630) may significantly reduce bronchitis symptom severity and working inability. Approved as a medicine for respiratory infections in multiple countries. RCT showed working inability decreased to 16% vs 43% in placebo group after 7 days.

Key Study Findings

Other
Research Landscape and Emerging Trends in Herbal Medicine for Pediatric Respiratory Tract Infections: A CiteSpace-Based …
Dose: None مقابل: None Outcome: research landscape of herbal medicine for pediatric RTIs التأثير: None None

المجتمع المدروس: pediatric patients with respiratory tract infections

Systematic Review
Pelargonium sidoides - from ethnopharmacology to evidence-based medicine: a systematic review.
Dose: None مقابل: None Outcome: clinical efficacy of Pelargonium sidoides for respiratory tract … التأثير: None None

المجتمع المدروس: patients with acute bronchitis, rhinosinusitis, and tonsillopharyngitis

Randomized Controlled Trial n=240 1 weeks Double-blind
Efficacy and Safety of YJP-40 in Patients with Acute Bronchitis: A Randomized, Double-Blind, Parallel Group …
Dose: None مقابل: Umckamin syrup (P. sidoides extract alone) Outcome: Change in bronchitis severity score (BSS) at day … التأثير: BSS change: -4.31 vs -4.36 non-inferiority demonstrated

المجتمع المدروس: Patients with acute bronchitis from 7 hospitals

Randomized Controlled Trial 1 weeks Double-blind
Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment …
Dose: Ivy leaf extract + Coptidis rhizome مقابل: Pelargonium sidoides extract Outcome: Bronchitis severity score (BSS) التأثير: None None

المجتمع المدروس: Adults with acute bronchitis

Review
Chronobiological Efficacy of Combined Therapy of Pelargonium Sidoides and Melatonin in Acute and Persistent Cases …
Dose: None مقابل: None Outcome: inflammation markers التأثير: None None

المجتمع المدروس: Covid-19

Randomized Controlled Trial n=591 1.0 weeks Open-label
Safety of Pelargonium extract EPs 7630 in young children with acute bronchitis.
Dose: 7.2% مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: Ab received eps 7630 syrup or solution for 7 days

Key Statistics

8

الدراسات

2000

المشاركون

Positive

A

التقييم

Referenced Papers

Frontiers in pediatrics 2023 7 اقتباسات
Multidisciplinary respiratory medicine 2023 4 اقتباسات
Complementary therapies in … 2020 36 اقتباسات
The Cochrane database … 2013 125 اقتباسات
Phytomedicine : international … 2008 100 اقتباسات
The Cochrane database … 2008 71 اقتباسات
Phytomedicine : international … 2007 39 اقتباسات
Wiener medizinische Wochenschrift … 2007 23 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
30 drops (1.5 mL) liquid extract 3x/day or 20 mg EPs 7630 tablets 3x/day
duration:
7-14 days

الحد الأعلى: No established UL

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Positive --
None -- Positive --
None 1 weeks Neutral 240
Ivy leaf extract + Coptidis rhizome 1 weeks Positive --
None -- Mixed --
7.2% 1.0 weeks Positive 591
83.6% 10.4 weeks Mixed 505
None -- Positive 2195

أفضل وقت للتناول: At onset of respiratory symptoms; 3x daily for up to 14 days

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Gastrointestinal discomfort (rare)
  • Allergic skin reactions (rare)
  • Nosebleeds (rare)
  • Hepatotoxicity (very rare, case reports)

التفاعلات المعروفة

  • Anticoagulants (theoretical increased bleeding risk due to coumarin content)
  • Immunosuppressant medications (may modulate immune function)

الحد الأقصى المسموح به: No established UL

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Pelargonium sidoides help with Acute Bronchitis?
Based on 8 studies with 2,000 participants, there is strong evidence from multiple clinical trials that Pelargonium sidoides may support Acute Bronchitis management. Our evidence grade is A (Strong Evidence).
How much Pelargonium sidoides should I take for Acute Bronchitis?
Studies have used various dosages. A commonly studied range is 30 drops (1.5 mL) liquid extract 3x/day or 20 mg EPs 7630 tablets 3x/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Pelargonium sidoides?
Reported side effects may include Gastrointestinal discomfort (rare), Allergic skin reactions (rare), Nosebleeds (rare), Hepatotoxicity (very rare, case reports). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Pelargonium sidoides and Acute Bronchitis?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 8 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

مكونات أخرى لـ Acute Bronchitis

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.